Theradiag
Theradiag Preliminary H1 2021 Revenues up 12 Percent
The revenue increase was driven by increased sales of the company's theranostic products, with strong growth in the US market.
Theradiag 2020 Revenues up 8 Percent
The French firm attributed the revenue increase to strong sales of its theranostics products, which include its therapeutic drug monitoring tests.
Theradiag Gets CE Marks for Four New Biotherapy Monitoring Test Kits
The kits are designed to run on Theradiag's i-Track 10 testing system and the IDS-iSYS automated analyzer from Immunodiagnostic Systems.
Theradiag Preliminary H1 2020 Revenues Down 2 Percent
The French diagnostics firm said the revenue decline was driven by a 17 percent drop in revenues from its in vitro diagnostics operations.
Mar 18, 2020
Theradiag 2019 Revenues Grow 8 Percent
Nov 20, 2019
Theradiag Applies CE Mark to i-Track Analyzer
Jan 16, 2019
Theradiag Gets CE Mark for Cosentyx Response Kit
Sep 21, 2018
Theradiag Reports 9 Percent Decline in H1 Revenues
Dec 22, 2017
Theradiag, Merck Partner on Remicade Monitoring Kits
May 12, 2017